Investor Presentaiton slide image

Investor Presentaiton

Research Services (Syngene): A global CRO delivering innovative solutions $ THE small Offering integrated research, development and manufacturing services for both and large molecules, antibody-drug conjugates and oligonucleotides backed by best-in-class bioinformatic services Combining world class research expertise, technology and infrastructure to reduce costs and time to market Talented scientific and techno-commercial teams, led by experienced management, moving beyond cost arbitrage to innovation. World class infrastructure audited successfully by US FDA, EMA, AAALAC and major life sciences partners 360+ active marquee clients across multiple sectors World-class R&D and manufacturing infrastructure spread over 1.9 million square feet 5000+ strong pool of employees, 4,200+ scientists Strong track record of top-line growth with best-in-class EBITDA margins (30+%) and Net Profit margin (high teens to low 20's) Listed in India on BSE and NSE in 2015 Touching a billion lives through affordable innovation Biocon 12
View entire presentation